Tumor vasculature and microenvironment normalization: a possible mechanism of antiangiogenesis therapy

Area of Science:

• Oncology
• Cancer Biology
• Medical Research

Background:

• Tumor antiangiogenesis therapy has been used for over 30 years, but its precise mechanisms are not fully understood.
• Tumor vasculature often exhibits abnormal structure and function due to an imbalance favoring proangiogenesis factors.
• This abnormal vasculature creates a detrimental tumor microenvironment characterized by poor perfusion, hypoxia, and elevated interstitial fluid pressure.

Purpose of the Study:

• To explore the hypothesis that antiangiogenesis therapy can transiently normalize tumor vasculature and its microenvironment.
• To investigate the potential of this normalization to enhance the efficacy of chemoradiotherapy.

Main Methods:

• The study reviews existing literature and research on tumor antiangiogenesis therapy.
• It analyzes the effects of antiangiogenesis on tumor vasculature and the tumor microenvironment.
• The research considers the implications for combining antiangiogenesis with chemoradiotherapy.

Main Results:

• Antiangiogenesis therapy may transiently normalize abnormal tumor vasculature and the associated microenvironment.
• This normalization can potentially improve the delivery of chemotherapeutics and increase tumor cell sensitivity to radiation.
• The findings suggest a new strategy for integrating antiangiogenesis with traditional chemoradiotherapy.

Conclusions:

• Antiangiogenesis therapy holds promise for improving chemoradiotherapy outcomes by normalizing the tumor microenvironment.
• Further research is warranted to fully elucidate the mechanisms and optimize combination strategies.
• This approach offers a novel perspective for enhancing cancer treatment efficacy.